| Serial Number | 79093385 |
| Word Mark | TG THROMBOGENICS |
| Filing Date | Tuesday, November 30, 2010 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, May 13, 2022 |
| Registration Number | 4047607 |
| Registration Date | Tuesday, November 1, 2011 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 16, 2011 |
| Indication of Colors claimed | The color(s) red and grey is/are claimed as a feature of the mark. |
| Pseudo Mark | TG THROMBO GENICS |
| Goods and Services | Chemical preparations and substances for use in the manufacture of pharmaceuticals |
| Goods and Services | Pharmaceutical preparations for treatment of diseases and disorders, namely, ophthalmic and visual disorders, vascular and cardiovascular disorders, cardiac diseases, stroke, inflammation, hypertension, pulmonary hypertension, edema, immune system disorders, immune system related disorders, eye diseases, blood disorders, thrombotic diseases and cancer; veterinary preparations for treatment of diseases and disorders in mammalians, namely, ophthalmic and visual disorders, vascular and cardiovascular disorders, cardiac diseases, stroke, inflammation, hypertension, pulmonary hypertension, edema, immune system disorders, immune system related disorders, eye diseases, blood disorders, thrombotic diseases and cancer; sanitary preparations for medical purposes; dietetic foods adapted for medical use, food for babies; medical plasters; material for stopping teeth, dental wax; disinfectants for medical instruments, for hygienic purposes, and for use in medical surgery procedures; preparations for destroying vermin; fungicides, herbicides; biopharmaceutical preparations, namely, anticoagulants, anti angiogenic drugs, anticancer drugs, cardiovascular drugs, protease enzymes, protease inhibitors, antibodies, plasmins, truncated plasmins, microplasmins, plasminogens, truncated plasminogens, microplasminogens, plasminogen activators, staphylokinases for the treatment diseases and disorders, namely, ophthalmic and visual disorders, vascular and cardiovascular disorders, cardiac diseases, stroke, inflammation, hypertension, pulmonary hypertension, edema, immune system disorders, immune system related disorders, eye diseases, blood disorders, thrombotic diseases and cancer; diagnostic medical reagents, chemicals and biological materials, namely, antigen and diagnostic kits consisting primarily of monoclonal and/or polyclonal antibodies, buffers, and reagents for medical laboratory use in disease testing |
| Goods and Services | Medical services; veterinary services; medical, veterinary and pharmaceutical advisory and consultancy services; medical services, namely, therapeutic, prognostic and diagnostic testing services |
| Description of Mark | The mark consists of the letters "TG" in grey and the word "thrombogenics" in red with a grey vertical line separating the literal elements of the mark. |
| Goods and Services | Scientific and technological services, namely, scientific research and design of new products in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder prevention, and in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder treatment; industrial analysis and product research services in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder prevention and in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder treatment; pharmaceutical, biopharmaceutical, medical, biomedical, biological, biochemical, toxicological and clinical research and product development of diagnostic tests and kits, biopharmaceutical preparations and drugs, and medicines; biopharmaceutical product evaluation; biological, biochemical, pharmaceutical, medical, toxicological and clinical research, scientific research for medical purposes in the treatment of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer diseases and disorders; development services in the field of new biopharmaceutical drugs, preparations and medicines for ophthalmic, vascular and cancer pathologies |
| NOT AVAILABLE | "THROMBOGENICS" |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Friday, May 11, 2018 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Friday, May 11, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, May 13, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Friday, May 11, 2018 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Oxurion NV |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | BE |
| Party Name | ThromboGenics NV |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | B-3001 Heverlee BE |
| Party Name | ThromboGenics NV |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | B-3001 Heverlee BE |
| Event Date | Event Description |
| Thursday, March 3, 2011 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, March 4, 2011 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Tuesday, March 8, 2011 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 8, 2011 | ASSIGNED TO EXAMINER |
| Saturday, March 12, 2011 | APPLICATION FILING RECEIPT MAILED |
| Friday, March 18, 2011 | NON-FINAL ACTION WRITTEN |
| Saturday, March 19, 2011 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, March 22, 2011 | REFUSAL PROCESSED BY MPU |
| Tuesday, March 22, 2011 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, April 9, 2011 | REFUSAL PROCESSED BY IB |
| Friday, June 17, 2011 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, June 17, 2011 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 17, 2011 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, June 18, 2011 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, July 12, 2011 | ASSIGNED TO LIE |
| Wednesday, July 13, 2011 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, July 27, 2011 | NOTICE OF PUBLICATION |
| Tuesday, August 16, 2011 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 1, 2011 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, February 1, 2012 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Friday, June 8, 2012 | FINAL DISPOSITION PROCESSED |
| Friday, June 8, 2012 | FINAL DISPOSITION NOTICE SENT TO IB |
| Saturday, July 28, 2012 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, May 1, 2018 | TEAS SECTION 71 RECEIVED |
| Friday, May 11, 2018 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Friday, May 11, 2018 | REGISTERED - PARTIAL SEC 71 ACCEPTED |
| Friday, May 11, 2018 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
| Friday, September 28, 2018 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, January 11, 2019 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Saturday, January 26, 2019 | INVALIDATION PROCESSED |
| Saturday, January 26, 2019 | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Friday, March 8, 2019 | PARTIAL INVALIDATION PROCESSED BY THE IB |
| Thursday, June 13, 2019 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Sunday, November 1, 2020 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
| Thursday, December 17, 2020 | INTERNATIONAL REGISTRATION RENEWED |
| Friday, May 13, 2022 | CANCELLED SECTION 71 |
| Friday, January 13, 2023 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Wednesday, March 1, 2023 | INVALIDATION PROCESSED |
| Wednesday, March 1, 2023 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Tuesday, April 11, 2023 | TOTAL INVALIDATION PROCESSED BY THE IB |
| Thursday, January 8, 2026 | NEW REPRESENTATIVE AT IB RECEIVED |